CN103736003A - 一种治疗乳腺增生的药物 - Google Patents
一种治疗乳腺增生的药物 Download PDFInfo
- Publication number
- CN103736003A CN103736003A CN201310677027.XA CN201310677027A CN103736003A CN 103736003 A CN103736003 A CN 103736003A CN 201310677027 A CN201310677027 A CN 201310677027A CN 103736003 A CN103736003 A CN 103736003A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- rhizoma
- medicament
- breast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 206010020718 Hyperplasia Diseases 0.000 title abstract description 4
- 210000000582 Semen Anatomy 0.000 claims abstract description 13
- 241000218176 Corydalis Species 0.000 claims abstract description 5
- 235000004347 Perilla Nutrition 0.000 claims abstract description 4
- 240000003877 Perilla frutescens Species 0.000 claims abstract description 4
- 235000004348 Perilla frutescens Nutrition 0.000 claims abstract description 4
- 240000001816 Prunella vulgaris Species 0.000 claims abstract description 4
- 241001038563 Pseudostellaria Species 0.000 claims abstract description 4
- 229940079593 drugs Drugs 0.000 claims description 9
- 241000717739 Boswellia sacra Species 0.000 claims description 4
- 241000209020 Cornus Species 0.000 claims description 4
- 241000283956 Manis Species 0.000 claims description 4
- 241000217407 Margaritifera Species 0.000 claims description 4
- 241001057584 Myrrha Species 0.000 claims description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 235000014375 Curcuma Nutrition 0.000 claims description 3
- 241001092070 Eriobotrya Species 0.000 claims description 3
- 241001523579 Ostrea Species 0.000 claims description 3
- 240000002123 Curcuma aromatica Species 0.000 claims 1
- 210000000481 Breast Anatomy 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 7
- 230000000638 stimulation Effects 0.000 abstract description 4
- 239000000262 estrogen Substances 0.000 abstract description 3
- 239000004863 Frankincense Substances 0.000 abstract description 2
- 230000002411 adverse Effects 0.000 abstract description 2
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 244000144725 Amygdalus communis Species 0.000 abstract 1
- 235000011437 Amygdalus communis Nutrition 0.000 abstract 1
- 240000001992 Angelica archangelica Species 0.000 abstract 1
- 210000003056 Antler Anatomy 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000004499 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 240000004563 Curculigo orchioides Species 0.000 abstract 1
- 240000005967 Eriobotrya japonica Species 0.000 abstract 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 229940010454 Licorice Drugs 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 240000004600 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000010674 Prunella vulgaris Nutrition 0.000 abstract 1
- 235000020224 almond Nutrition 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 235000014063 licorice root Nutrition 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 36
- 230000036407 pain Effects 0.000 description 36
- 210000004185 Liver Anatomy 0.000 description 24
- 239000008280 blood Substances 0.000 description 22
- 210000004369 Blood Anatomy 0.000 description 20
- 210000000952 Spleen Anatomy 0.000 description 17
- 210000004072 Lung Anatomy 0.000 description 13
- 210000002216 Heart Anatomy 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 230000001737 promoting Effects 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 210000003734 Kidney Anatomy 0.000 description 8
- 210000002264 Mammary Glands, Animal Anatomy 0.000 description 8
- 210000004293 Mammary Glands, Human Anatomy 0.000 description 8
- 210000001015 Abdomen Anatomy 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 7
- 210000003205 Muscles Anatomy 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 230000001717 pathogenic Effects 0.000 description 7
- 230000001105 regulatory Effects 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 6
- 208000002173 Dizziness Diseases 0.000 description 6
- 229940088597 Hormone Drugs 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 210000002784 Stomach Anatomy 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 201000000736 amenorrhea Diseases 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- 210000000988 Bone and Bones Anatomy 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 210000000232 Gallbladder Anatomy 0.000 description 5
- 208000008454 Hyperhidrosis Diseases 0.000 description 5
- 230000002269 spontaneous Effects 0.000 description 5
- 230000002522 swelling Effects 0.000 description 5
- 208000006673 Asthma Diseases 0.000 description 4
- 206010019233 Headache Diseases 0.000 description 4
- 206010027327 Menstrual disease Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 231100000614 Poison Toxicity 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000668709 Dipterocarpus costatus Species 0.000 description 3
- 206010022114 Injury Diseases 0.000 description 3
- 210000000936 Intestines Anatomy 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 230000001914 calming Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000001076 estrogenic Effects 0.000 description 3
- 235000019525 fullness Nutrition 0.000 description 3
- 210000004914 menses Anatomy 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 230000001225 therapeutic Effects 0.000 description 3
- 206010003549 Asthenia Diseases 0.000 description 2
- 210000001124 Body Fluids Anatomy 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 241000407170 Curcuma Species 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010013990 Dysuria Diseases 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 210000003026 Hypopharynx Anatomy 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010022437 Insomnia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 210000000214 Mouth Anatomy 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010072736 Rheumatic disease Diseases 0.000 description 2
- 206010040872 Skin infection Diseases 0.000 description 2
- 206010040943 Skin ulcer Diseases 0.000 description 2
- 206010068760 Ulcers Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003213 activating Effects 0.000 description 2
- 230000000202 analgesic Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 201000008275 breast carcinoma Diseases 0.000 description 2
- 230000001684 chronic Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000003419 expectorant Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002496 gastric Effects 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002175 menstrual Effects 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000000414 obstructive Effects 0.000 description 2
- 244000052769 pathogens Species 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000025627 positive regulation of urine volume Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000003014 reinforcing Effects 0.000 description 2
- 230000000552 rheumatic Effects 0.000 description 2
- 230000000630 rising Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000004936 stimulating Effects 0.000 description 2
- 210000001519 tissues Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000002936 tranquilizing Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000210 Abortion Diseases 0.000 description 1
- 206010003883 Azoospermia Diseases 0.000 description 1
- 208000002894 Beriberi Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010006313 Breast tenderness Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 210000002808 Connective Tissue Anatomy 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010061428 Decreased appetite Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010013023 Diphtheria Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000001848 Dysentery Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000001780 Epistaxis Diseases 0.000 description 1
- 210000000981 Epithelium Anatomy 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010016286 Febrile disease Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 206010018830 Haematemesis Diseases 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- 208000005252 Hepatitis A Diseases 0.000 description 1
- 206010019780 Hepatitis infectious Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 210000001624 Hip Anatomy 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 210000003127 Knee Anatomy 0.000 description 1
- 210000002414 Leg Anatomy 0.000 description 1
- 208000004396 Mastitis Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 230000036740 Metabolism Effects 0.000 description 1
- 210000004080 Milk Anatomy 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010029410 Night sweats Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 206010067572 Oestrogenic effect Diseases 0.000 description 1
- 208000008634 Oligospermia Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N Picric acid Chemical compound data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='300px' height='300px' viewBox='0 0 300 300'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='300.0' height='300.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 237.8,148.0 L 221.6,148.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0 atom-0 atom-1' d='M 221.6,148.0 L 205.4,148.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 205.4,148.0 L 180.7,190.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 193.1,149.5 L 175.8,179.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-12 atom-1' d='M 180.7,105.2 L 205.4,148.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 180.7,190.8 L 188.5,204.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 188.5,204.4 L 196.3,217.9' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-2 atom-6' d='M 180.7,190.8 L 131.2,190.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 194.0,253.3 L 191.7,257.3' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 191.7,257.3 L 189.4,261.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 230.6,238.6 L 234.5,238.6' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 234.5,238.6 L 238.4,238.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 230.6,228.7 L 234.5,228.7' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 234.5,228.7 L 238.4,228.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 131.2,190.8 L 106.5,148.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 136.1,179.5 L 118.8,149.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 106.5,148.0 L 94.4,148.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 94.4,148.0 L 82.3,148.0' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-7 atom-11' d='M 106.5,148.0 L 131.2,105.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 48.0,132.3 L 45.7,128.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 45.7,128.4 L 43.5,124.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 41.4,165.2 L 39.1,169.2' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 39.1,169.2 L 36.8,173.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 50.0,170.2 L 47.7,174.2' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 47.7,174.2 L 45.4,178.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 131.2,105.2 L 180.7,105.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 138.7,115.1 L 173.3,115.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 180.7,105.2 L 187.4,93.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 187.4,93.6 L 194.0,82.1' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 230.6,62.4 L 234.5,62.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 234.5,62.4 L 238.4,62.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 200.6,44.2 L 198.3,40.3' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 198.3,40.3 L 196.1,36.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 192.0,49.1 L 189.8,45.2' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 189.8,45.2 L 187.5,41.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='248.9' y='157.9' class='atom-0' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='262.6' y='157.9' class='atom-0' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='199.5' y='243.5' class='atom-3' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='213.1' y='235.6' class='atom-3' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='174.8' y='286.4' class='atom-4' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='188.4' y='278.5' class='atom-4' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='248.9' y='243.5' class='atom-5' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='51.1' y='157.9' class='atom-8' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='64.8' y='150.0' class='atom-8' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='26.4' y='115.1' class='atom-9' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='40.1' y='107.2' class='atom-9' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='26.4' y='200.7' class='atom-10' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='199.5' y='72.3' class='atom-13' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='213.1' y='64.4' class='atom-13' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='248.9' y='72.3' class='atom-14' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='262.6' y='64.4' class='atom-14' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='174.8' y='29.5' class='atom-15' style='font-size:19px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='85px' height='85px' viewBox='0 0 85 85'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='85.0' height='85.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 69.6,41.4 L 63.6,41.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0 atom-0 atom-1' d='M 63.6,41.4 L 57.7,41.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 57.7,41.4 L 50.7,53.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 54.2,41.9 L 49.3,50.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-12 atom-1' d='M 50.7,29.3 L 57.7,41.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 50.7,53.6 L 53.6,58.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 53.6,58.6 L 56.5,63.6' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-2 atom-6' d='M 50.7,53.6 L 36.7,53.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 55.8,69.1 L 53.8,72.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 53.8,72.4 L 51.9,75.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 62.3,67.1 L 66.0,67.1' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 66.0,67.1 L 69.7,67.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 62.3,64.3 L 66.0,64.3' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 66.0,64.3 L 69.7,64.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 36.7,53.6 L 29.7,41.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 38.1,50.4 L 33.2,41.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 29.7,41.4 L 25.0,41.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 25.0,41.4 L 20.3,41.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-7 atom-11' d='M 29.7,41.4 L 36.7,29.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 14.4,39.3 L 12.5,35.9' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 12.5,35.9 L 10.6,32.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 12.5,44.1 L 10.6,47.5' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 10.6,47.5 L 8.6,50.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 15.0,45.5 L 13.0,48.9' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-8 atom-10' d='M 13.0,48.9 L 11.1,52.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 36.7,29.3 L 50.7,29.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 38.8,32.1 L 48.6,32.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 50.7,29.3 L 53.2,24.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 53.2,24.9 L 55.8,20.5' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 62.3,17.2 L 66.0,17.2' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 66.0,17.2 L 69.7,17.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 57.7,14.3 L 55.7,11.0' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 55.7,11.0 L 53.8,7.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 55.2,15.7 L 53.3,12.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 53.3,12.4 L 51.4,9.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='69.9' y='44.4' class='atom-0' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='74.0' y='44.4' class='atom-0' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='55.9' y='68.7' class='atom-3' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='60.0' y='66.3' class='atom-3' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='48.9' y='80.8' class='atom-4' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='53.0' y='78.4' class='atom-4' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='69.9' y='68.7' class='atom-5' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='13.9' y='44.4' class='atom-8' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='18.0' y='42.0' class='atom-8' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='6.9' y='32.3' class='atom-9' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='11.0' y='29.9' class='atom-9' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='6.9' y='56.6' class='atom-10' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='55.9' y='20.2' class='atom-13' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='60.0' y='17.8' class='atom-13' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >+</text>
<text x='69.9' y='20.2' class='atom-14' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='74.0' y='17.8' class='atom-14' style='font-size:3px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >-</text>
<text x='48.9' y='8.0' class='atom-15' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 206010065347 Premenstrual pain Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000008425 Protein Deficiency Diseases 0.000 description 1
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 1
- 208000008128 Pulmonary Tuberculosis Diseases 0.000 description 1
- 208000009146 Rhinoscleroma Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='300px' height='300px' viewBox='0 0 300 300'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='300.0' height='300.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 173.5,127.3 L 151.9,109.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0 atom-0 atom-1' d='M 173.9,120.2 L 158.8,107.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-27 atom-0 atom-5' d='M 173.5,127.3 L 200.1,117.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 151.9,109.0 L 157.0,81.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 157.0,81.2 L 183.6,71.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 162.9,85.1 L 181.5,78.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 183.6,71.6 L 205.2,89.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 205.2,89.9 L 200.1,117.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 198.9,93.1 L 195.3,112.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-5 atom-6' d='M 200.1,117.8 L 221.7,136.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 221.7,136.1 L 248.3,126.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-6 atom-9' d='M 221.7,136.1 L 216.6,163.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-6 atom-9' d='M 215.3,139.2 L 211.8,158.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 248.3,126.6 L 269.9,144.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 216.6,163.9 L 190.0,173.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-9 atom-22' d='M 216.6,163.9 L 238.2,182.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 190.0,173.4 L 168.4,155.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 183.1,175.0 L 168.0,162.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-28 atom-10 atom-21' d='M 190.0,173.4 L 184.9,201.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 168.4,155.1 L 141.8,164.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 141.8,164.6 L 136.7,192.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 146.6,169.8 L 143.0,189.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 136.7,192.5 L 128.1,195.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 128.1,195.5 L 119.5,198.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-13 atom-20' d='M 136.7,192.5 L 158.2,210.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-14 atom-15' d='M 101.6,194.8 L 95.1,189.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-14 atom-15' d='M 95.1,189.3 L 88.5,183.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-15 atom-16' d='M 88.5,183.7 L 61.8,193.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 61.8,193.2 L 55.3,187.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 55.3,187.6 L 48.7,182.0' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-17 atom-18' d='M 30.8,178.3 L 22.2,181.3' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-17 atom-18' d='M 22.2,181.3 L 13.6,184.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-17 atom-19' d='M 42.0,165.2 L 43.7,156.1' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-17 atom-19' d='M 43.7,156.1 L 45.4,147.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-20 atom-21' d='M 158.2,210.8 L 184.9,201.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-20 atom-21' d='M 160.3,204.0 L 179.0,197.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-22 atom-23' d='M 238.2,182.2 L 233.1,210.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-22 atom-23' d='M 243.0,187.4 L 239.4,206.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-29 atom-27 atom-22' d='M 264.8,172.7 L 238.2,182.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23 atom-23 atom-24' d='M 233.1,210.1 L 254.6,228.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-24 atom-24 atom-25' d='M 254.6,228.4 L 281.3,218.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-24 atom-24 atom-25' d='M 256.7,221.6 L 275.4,214.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-25 atom-25 atom-26' d='M 281.3,218.8 L 286.4,191.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-26 atom-26 atom-27' d='M 286.4,191.0 L 264.8,172.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-26 atom-26 atom-27' d='M 279.5,192.6 L 264.4,179.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='106.6' y='207.7' class='atom-14' style='font-size:11px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='36.9' y='180.5' class='atom-17' style='font-size:11px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
</svg>
 data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='85px' height='85px' viewBox='0 0 85 85'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='85.0' height='85.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 48.6,35.6 L 42.5,30.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0 atom-0 atom-1' d='M 48.8,33.6 L 44.5,29.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-27 atom-0 atom-5' d='M 48.6,35.6 L 56.2,32.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 42.5,30.4 L 44.0,22.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 44.0,22.5 L 51.5,19.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 45.6,23.6 L 50.9,21.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 51.5,19.8 L 57.6,25.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 57.6,25.0 L 56.2,32.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 55.8,25.9 L 54.8,31.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-5 atom-6' d='M 56.2,32.9 L 62.3,38.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 62.3,38.1 L 69.9,35.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-6 atom-9' d='M 62.3,38.1 L 60.9,45.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-6 atom-9' d='M 60.5,39.0 L 59.5,44.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 69.9,35.4 L 76.0,40.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 60.9,45.9 L 53.3,48.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-9 atom-22' d='M 60.9,45.9 L 67.0,51.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 53.3,48.6 L 47.2,43.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 51.4,49.1 L 47.1,45.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-28 atom-10 atom-21' d='M 53.3,48.6 L 51.9,56.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 47.2,43.5 L 39.7,46.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 39.7,46.1 L 38.2,54.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 41.0,47.6 L 40.0,53.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 38.2,54.0 L 35.5,55.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 35.5,55.0 L 32.7,56.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-13 atom-20' d='M 38.2,54.0 L 44.3,59.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-14 atom-15' d='M 28.7,55.0 L 26.6,53.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-14 atom-15' d='M 26.6,53.3 L 24.6,51.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-15 atom-16' d='M 24.6,51.5 L 17.0,54.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 17.0,54.2 L 15.0,52.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 15.0,52.5 L 12.9,50.8' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-17 atom-18' d='M 8.9,49.8 L 6.1,50.8' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-17 atom-18' d='M 6.1,50.8 L 3.4,51.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-17 atom-19' d='M 11.3,47.1 L 11.8,44.1' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-17 atom-19' d='M 11.8,44.1 L 12.3,41.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-20 atom-21' d='M 44.3,59.2 L 51.9,56.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-20 atom-21' d='M 44.9,57.3 L 50.2,55.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-22 atom-23' d='M 67.0,51.1 L 65.5,59.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-22 atom-23' d='M 68.3,52.6 L 67.3,58.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-29 atom-27 atom-22' d='M 74.5,48.4 L 67.0,51.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23 atom-23 atom-24' d='M 65.5,59.0 L 71.7,64.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-24 atom-24 atom-25' d='M 71.7,64.2 L 79.2,61.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-24 atom-24 atom-25' d='M 72.2,62.3 L 77.5,60.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-25 atom-25 atom-26' d='M 79.2,61.5 L 80.6,53.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-26 atom-26 atom-27' d='M 80.6,53.6 L 74.5,48.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-26 atom-26 atom-27' d='M 78.7,54.1 L 74.4,50.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='28.9' y='59.7' class='atom-14' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='9.1' y='52.1' class='atom-17' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
</svg>
 C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 1
- 229960001603 Tamoxifen Drugs 0.000 description 1
- 210000001138 Tears Anatomy 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 231100000765 Toxin Toxicity 0.000 description 1
- 210000003932 Urinary Bladder Anatomy 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 206010052769 Vertigos Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000001154 acute Effects 0.000 description 1
- 231100000494 adverse effect Toxicity 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001833 anti-estrogenic Effects 0.000 description 1
- 230000001166 anti-perspirant Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000001174 ascending Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding Effects 0.000 description 1
- 231100000319 bleeding Toxicity 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000008286 diarrhea Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary Effects 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- 230000001815 facial Effects 0.000 description 1
- 230000001605 fetal Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002607 hemopoietic Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003447 ipsilateral Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035786 metabolism Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000036616 oligospermia Effects 0.000 description 1
- 231100000528 oligospermia Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229940114148 picric acid Drugs 0.000 description 1
- 230000003389 potentiating Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000035812 respiration Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 229950002929 trinitrophenol Drugs 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Abstract
本发明公开了一种治疗乳腺增生的药物。它由下述重量的原料药制成：柴胡20克，鸡血藤20克，熟地黄15克，乳香10克，没药10克，当归20克，香附15克，夏枯草10克，牡蛎15克，陈皮20克，太子参15克，白术15克，茯苓15克，青皮15克，白芍10克，穿山甲10克，鹿角10克，郁金10克，延胡索15克，川芎10克，桂枝10克，酸枣仁20克，珍珠母10克，枇杷叶20克，紫苏12克，杏仁10克，五加皮20克，菟丝子15克，仙茅10克和甘草5克。本发明可以减轻雌激素对乳房的不良刺激；对不同程度的乳腺主质和间质增生，均有治疗作用。
Description
一种治疗乳腺增生的药物
技术领域
[0001] 本发明涉及一种治疗乳腺增生的药物，属中药领域。
背景技术
[0002] 乳腺增生是女性最常见的乳房疾病。该病是指乳腺上皮和纤维组织增生，乳腺组织导管和乳小叶在结构上的退行性病变及进行性结缔组织的生长。其发病原因主要是由于内分泌激素失调。症状常为胀痛或刺痛，疼痛以乳房肿块处为主，亦可向患侧腋窝、胸胁或肩背部放射；疼痛常于月经前数天出现或加重，行经后疼痛明显减轻或消失。精神刺激和饮食结构不合理，都可导致乳腺增生。还有许多人为因素和生活方式因素，人流、不生育或30岁以上生育，不哺乳，服用含激素的保健品或佩戴过紧的胸罩等等，都可能引起乳腺增生。
[0003]目前治疗乳腺增生病的西药主要是抗雌激素药三苯氧胺、乳癖消、天冬素片、平消片、囊癖灵等药物。这些药物在缓解乳腺增生症状、抑制病情方面确实起到了一定作用，但激素类药物疗效不巩固、且副作用大。
发明内容
[0004] 本发明的目的是提供一种治疗乳腺增生的药物，该药物能够改善乳腺增生临床症状，改善本病对患者带来的不利影响。
[0005] 本发明解决技术 问题所采取的技术方案是:一种治疗乳腺增生的药物，其特征是，由下述重量的原料药制成:柴胡20克，鸡血藤20克，熟地黄15克，乳香10克，没药10克，当归20克，香附15克，夏枯草10克，牡蛎15克，陈皮20克，太子参15克，白术15克，茯苓15克，青皮15克，白芍10克，穿山甲10克，鹿角10克，郁金10克，延胡索15克，川芎10克，桂枝10克，酸枣仁20克，珍珠母10克，枇杷叶20克，紫苏12克，杏仁10克，五加皮20克，菟丝子15克，仙茅10克和甘草5克。
[0006] 配制及服用方法:水煎煮，分两次早晚服用。7天为I个疗程。
[0007] 药理作用:
[0008] 柴胡:辛、苦，微寒。归肝、胆、肺经。功能与主治:疏散退热，疏肝解郁，升举阳气。用于感冒发热，寒热往来，胸胁胀痛，月经不调，子宫脱垂，脱肛。
[0009] 鸡血藤:苦、微甘，温；归肝经。补血活血，通经活络。本品气味柔和,走守兼备,能化阴生血，温通经脉，活血通络，推陈致新，有润而不燥、补而不滞，行而补破之特点，对血虚所致之风湿痹痛，淤滞疼痛及妇科诸证，均有良效。
[0010] 熟地黄:既善补血滋阴，又能补精益髓，主治一切血虚阴亏精少之症。主要功能养血滋阴、补精益髓，用于血虚萎黄、眩晕、心悸。
[0011] 乳香:调气活血，定痛，追毒。治气血凝滞、心腹疼痛，痈疮肿毒，跌打损伤，痛经，产后瘀血刺痛。
[0012] 没药:苦，辛，平，无毒。肝，脾，心，肾经。活血定痛，消肿生肌，主治跌打损伤，金疮，筋骨，心腹诸痛，症瘕，经闭，痈疽肿痛，疮疡溃后久不收口。[0013] 当归:甘辛，温。入心、肝、脾经。补血和血，调经止痛，润燥滑肠。治月经不调，经闭腹痛，癥瘕结聚，崩漏；血虚头痛，眩晕，痿痹；肠燥便难，赤痢后重；痈疽疮窃，跌扑损伤。
[0014] 香附:辛微苦甘，平。入肝、三焦经。理气解郁，止痛调经。治肝胃不和，气郁不舒，胸腹胁肋胀痛，痰饮痞满，月经不调，崩漏带下。
[0015] 夏枯草:苦辛，寒。入肝、胆经。清肝，散结。治瘰疬，瘿瘤，乳痈，乳癌，目珠夜痛，羞明流泪，头目眩晕，口眼歪斜，筋骨疼痛，肺结核，急性黄疸型传染性肝炎，血崩，带下。
[0016] 牡蛎:敛阴，潜阳，止汗，涩精，化痰，软坚。治眩晕，自汗，盗汗，遗精，淋池，崩漏，带下，瘰疬，瘿瘤。
[0017] 陈皮:苦、辛，温。归肺、脾经。理气健脾，燥湿化痰。用于胸脘胀满，食少吐泻，咳嗽痰多。
[0018] 太子参:性平，味甘微苦。功能主治:益气健脾，生津润肺。用于脾虚体弱、病后虚弱、气阴不足、自汗口渴、肺噪干咳。
[0019] 白术:苦甘，温。入脾、胃经。补脾，益胃，燥湿，和中，安胎。治脾胃气弱，不思饮食，倦怠少气，虚胀，泄湾，痰饮，水肿，黄疸，湿痹，小便不利，头晕，自汗，胎气不安。
[0020] 茯苓:甘淡，平。入心、脾、肺经。渗湿利水，益脾和胃，宁心安神。治小便不利，水肿胀满，痰饮咳逆，呕哕，泄泻，遗精，淋浊，惊悸，健忘。
[0021] 青皮:气温，味辛。入肝、胆经。疏肝破气，散结消痰。治胸胁胃脘疼痛，疝气，食积，乳肿，乳核，久疟癖块。
[0022] 白芍:苦酸，凉。入肝、脾经。养血柔肝，缓中止痛，敛阴收汗。治胸腹胁肋疼痛，自汗盗汗，阴虚发热。
[0023] 穿山甲:消肿溃痈，搜风活络，通经下乳。治痈疽疮种，风寒湿痹，月经停闭，乳汁不通。
[0024] 鹿角:行血，消肿，益肾。治疮疡肿毒，瘀血作痛，虚劳内伤，腰脊疼痛。
[0025] 郁金:辛苦，凉。入心、肺、肝经。行气解郁，凉血破瘀，治胸腹胁肋诸痛，失心癫狂，热病神昏，吐血，黄疸。
[0026] 延胡索:苦咸，凉。入肺、肾经。滋阴，降火，除烦，解毒。治热病伤阴，舌绎烦渴，发斑，骨蒸劳热，夜寐不宁，自汗盗汗，津伤便秘，吐血衄血，咽喉肿痛，痈肿，瘰疬，温毒发斑、目赤、白喉、疮毒。
[0027] 川芎:味辛，温。入肝、胆经。行气开郁，祛风燥湿，活血止痛。治风冷头痛旋晕，胁痛腹疼，寒痹筋挛，经闭，难产，产后瘀阻块痛，痈疽疮疡。用于月经不调，经闭痛经，瘕腹痛，胸胁刺痛，跌扑肿痛，头痛，风湿痹痛。
[0028] 桂枝:辛甘，温。入膀胱、心、肺经。发汗解肌，温经通脉。治风寒表证，肩背肢节酸疼，胸痹痰饮，经闭癥瘕。
[0029] 酸枣仁:甘、酸，平。归肝、胆、心经。功能与主治:养心补肝，宁心安神，敛汗，生津。用于虚烦不眠，惊悸多梦，体虚多汗，津伤口渴。
[0030] 珍珠母:咸，寒。归肝、心经。功能与主治:平肝潜阳，安神定惊，明目退醫。用于头痛眩晕，惊悸失眠，目赤翳障，视物昏花。
[0031]枇杷叶:苦，微寒。归肺、胃经。功能与主治:清肺止咳，降逆止呕。用于肺热咳嗽，气逆喘急，胃热呕逆，烦热口渴。[0032] 紫苏:辛，温。归肺经。功能与主治:降气化痰，止咳平喘，润肠通便。用于痰壅气逆，咳嗽气喘，肠燥便秘。
[0033] 杏仁:归肺、大肠经。功效:降气止咳平喘，润肠通便。主治:用于咳嗽气喘.胸满痰多，血虚津枯，肠燥便秘。
[0034] 五加皮:祛风除湿，补益肝肾，强筋壮骨，利水消肿。用于风湿痹病，筋骨痿软、儿行迟,体虚乏力,水肿,脚气。
[0035] 菟丝子:辛、甘，平。归肝、肾、脾经。功能与主治:补益肝肾，固精缩尿，安胎，明目，止泻；外用消风祛斑。用于肝肾不足，腰膝酸软，阳痿遗精，遗尿尿频。肾虚胎漏，胎动不安，目昏耳鸣，脾肾虚泻；外治白癜风。
[0036] 仙茅:补肾阳，强筋骨，散寒湿。治阳萎精冷，小便失禁，崩漏，心腹冷痛，腰脚冷痹，痈疽，瘰疬，阳虚冷泻。
[0037] 甘草:甘，平。归心、肺、脾、胃经。补脾益气，滋咳润肺，缓急解毒，调和百药。主治咽喉肿痛，痛疽疮疡，胃肠道溃疡以及解药毒、食物中毒等。
[0038] 西医认为乳腺增生是乳腺组织对雌激素的敏感性增高，孕激素相对分泌不足，使乳腺组织在高浓度雌激素的作用下，不能由增殖状态完全复旧，最终导致乳腺组织增生。西医对于乳腺增生的治疗是阻断高浓度雌激素的刺激，使增生的组织复原，乳房触痛消除。但西药只能阻断激素的作用环节，但不能很好地调节激素内分泌，所以此种疗法易反复。
[0039] 祖国医学将乳腺增生归属于中药“乳癖”范畴，认为本病多由情志不畅或思虑过度，导致肝失疏泄，气血不和，致经行不畅及经前乳房胀痛。本发明药物治疗乳腺增生具有疏肝解郁、行经止痛、补气健脾、活血化瘀、养安神等功效。能促进乳房血液运行，调节激素内分泌，可促进雌激素在肝脏的代谢，减轻雌激素对乳房的不良刺激；对不同程度的乳腺主质和间质增生，均有治疗作用。
[0040] 以下结合临床资料及典型病例对本发明的有益效果进一步说明。
[0041] 一、临床观察
[0042] 1、临床资料:选自选自2011年6月至2012年9月的门诊患者共149例，患者年龄在18 — 49岁之间。所有患者经B超或红外线扫描证实有乳腺小叶增生。
[0043] 2、治疗方法:服用本发明药物，水煎煮，分两次早晚服用。7天为I个疗程。
[0044] 3、疗效标准:
[0045] 治愈:治疗后疼痛消失，B超或红外线扫描证实乳腺组织正常；
[0046] 显效:疼痛消失，B超或红外线扫描证实乳腺组织缩小2/3以上；
[0047] 有效:疼痛减轻，B超或红外线扫描证实乳腺组织缩小；
[0048] 无效:疼痛未减轻或加重，B超或红外线扫描证实乳腺组织无变化。
[0049] 4、治疗结果:149例患者服用本方治疗后2-4个疗程后，治愈94例,显效28例,有效27例，无效O例。总有效率达到100%ο
[0050] 结论:通过2-4疗程的治疗，本发明治疗乳`腺增生的中药汤剂经临床试验，表明治疗乳腺癌疗效显著，94例临床痊愈者中，除失访I例，其余未见复发。
[0051] 二、典型病例
[0052] 病例一，杨某，女，32岁。患者于I年前开始经期乳房胀痛，感觉双乳房有肿块，月经前及行经期间两侧乳房胀痛，偶有刺疼，在当地医院诊断为:慢性纤维增生性乳房痛。经服用本发明药物治疗两个疗程，月经来潮经期再未出现乳房胀痛，乳房肿块变软变小，继进两个疗程，诸症悉除。I年内随访未复发。
[0053] 病例二，张某，女，36岁，患者近半年来感觉双乳房有肿块，质韧，边界不清，月经前及行经期间两侧乳房胀痛，经某医院检查诊断为乳腺囊性增生症，服用本发明治疗乳腺增生病的中药汤剂合物两疗程，现胀痛减轻，肿炔基本消失，继服一个疗程，肿块全部消失，诸症悉除。I年内随访未复发。
[0054] 病例三，齐某，女，42岁。患者多年双乳肿块伴经前疼痛，右乳上方可触及形态不规贝U、边界不明显、2~3厘米的肿块。质韧，边清。在医院诊断为乳腺增生。近因遇烦心之事，症状加重，经服用本发明治疗乳腺增生的中药汤剂四个疗程后，症状消失，双乳B超显示硬结消失，达到临床治愈，随访未见复发。
具体实施方式
[0055] 实施例1
[0056] 配方:柴胡20克，鸡血藤20克，熟地黄15克，乳香10克，没药10克，当归20克，香附15克，夏枯草10克，牡蛎15克，陈皮20克，太子参15克，白术15克，茯苓15克，青皮15克，白芍10克，穿山甲10克，鹿角10克，郁金10克，延胡索15克，川芎10克，桂枝10克，酸枣仁20克，珍珠母10克，枇杷叶20克，紫苏12克，杏仁10克，五加皮20克，菟丝子15克，仙茅10克和甘草5克。
[0057] 配制及服用方法:水煎煮，分两次早晚服用。7天为I个疗程。
Claims (1)
1.一种治疗乳腺增生的药物，其特征是，由下述重量的原料药制成:柴胡20克，鸡血藤20克，熟地黄15克，乳香10克，没药10克，当归20克，香附15克，夏枯草10克，牡蛎15克，陈皮20克，太子参15克，白术15克，茯苓15克，青皮15克，白芍10克，穿山甲10克，鹿角10克，郁金10克，延胡索15克，川芎10克，桂枝10克，酸枣仁20克，珍珠母10克，枇杷叶20克，紫苏12克，杏仁10克`，五加皮20克，菟丝子15克，仙茅10克和甘草5克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310677027.XA CN103736003A (zh) | 2013-12-12 | 2013-12-12 | 一种治疗乳腺增生的药物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310677027.XA CN103736003A (zh) | 2013-12-12 | 2013-12-12 | 一种治疗乳腺增生的药物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103736003A true CN103736003A (zh) | 2014-04-23 |
Family
ID=50493119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310677027.XA Pending CN103736003A (zh) | 2013-12-12 | 2013-12-12 | 一种治疗乳腺增生的药物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103736003A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104000988A (zh) * | 2014-06-16 | 2014-08-27 | 高勇 | 治疗乳腺增生的中药组合物及制备方法 |
| CN104027744A (zh) * | 2014-06-24 | 2014-09-10 | 湖州康企药业有限公司 | 一种治疗乳腺增生的药物 |
| CN107927920A (zh) * | 2017-12-19 | 2018-04-20 | 张毅松 | 一种治疗乳腺疾病的乳腺胸衣 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709288A (zh) * | 2004-06-17 | 2005-12-21 | 成都地奥制药集团有限公司 | 一种药物组合物及其制备方法和用途 |
| CN101837111A (zh) * | 2010-05-31 | 2010-09-22 | 赵晚乐 | 一种治疗乳腺增生的药物及其制备方法 |
| CN102526634A (zh) * | 2012-03-01 | 2012-07-04 | 王淑琳 | 一种治疗乳腺增生病的中药制剂 |
| CN102600432A (zh) * | 2011-10-18 | 2012-07-25 | 宋协勘 | 一种治疗乳腺增生的中药 |
| CN102727832A (zh) * | 2012-07-09 | 2012-10-17 | 王焕江 | 一种治疗乳腺疾病和子宫肌瘤的中药制剂及其制备方法 |
| CN103432412A (zh) * | 2013-08-30 | 2013-12-11 | 宋克垣 | 一种治疗乳腺增生的药物及其制备方法 |
-
2013
- 2013-12-12 CN CN201310677027.XA patent/CN103736003A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709288A (zh) * | 2004-06-17 | 2005-12-21 | 成都地奥制药集团有限公司 | 一种药物组合物及其制备方法和用途 |
| CN101837111A (zh) * | 2010-05-31 | 2010-09-22 | 赵晚乐 | 一种治疗乳腺增生的药物及其制备方法 |
| CN102600432A (zh) * | 2011-10-18 | 2012-07-25 | 宋协勘 | 一种治疗乳腺增生的中药 |
| CN102526634A (zh) * | 2012-03-01 | 2012-07-04 | 王淑琳 | 一种治疗乳腺增生病的中药制剂 |
| CN102727832A (zh) * | 2012-07-09 | 2012-10-17 | 王焕江 | 一种治疗乳腺疾病和子宫肌瘤的中药制剂及其制备方法 |
| CN103432412A (zh) * | 2013-08-30 | 2013-12-11 | 宋克垣 | 一种治疗乳腺增生的药物及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 周开: ""乳腺增生症的中医治则"", 《河南中医》, vol. 33, no. 5, 31 May 2013 (2013-05-31) * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104000988A (zh) * | 2014-06-16 | 2014-08-27 | 高勇 | 治疗乳腺增生的中药组合物及制备方法 |
| CN104027744A (zh) * | 2014-06-24 | 2014-09-10 | 湖州康企药业有限公司 | 一种治疗乳腺增生的药物 |
| CN107927920A (zh) * | 2017-12-19 | 2018-04-20 | 张毅松 | 一种治疗乳腺疾病的乳腺胸衣 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100584369C (zh) | 一种外用治疗痹症中药组合物 | |
| CN103690888A (zh) | 一种治疗痛风的中药水蜜丸及制备方法 | |
| CN104225479A (zh) | 一种治疗乳腺增生的中药组合物 | |
| CN103550695A (zh) | 一种治疗乳腺癌的药物 | |
| CN104983818A (zh) | 一种治疗妇科疾病的中药及其制备方法 | |
| CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
| CN104353019A (zh) | 舒经调脏的中药热敷袋及其制备方法 | |
| CN104225215A (zh) | 一种治疗失眠的中药 | |
| CN105664099A (zh) | 一种温补肾阳的中药组合物及其制备方法 | |
| CN105362650A (zh) | 一种用于治疗便秘的药物组合物及其应用方法 | |
| CN107137499A (zh) | 一种调理身体补充元气的热敷粉包 | |
| CN103977306A (zh) | 一种治疗乙型肝炎的药物及其制备方法 | |
| CN103599404A (zh) | 一种治疗颈椎病的中药汤剂 | |
| CN106309828A (zh) | 一种用于治疗慢性前列腺炎的中药组合物及其制备方法 | |
| CN103751702A (zh) | 一种治疗乳腺癌的中药 | |
| CN103736003A (zh) | 一种治疗乳腺增生的药物 | |
| CN103735934A (zh) | 一种治疗腰部疼痛的药物及其制备方法 | |
| CN103550383A (zh) | 一种治疗颈椎病的中药组合物 | |
| CN104740142A (zh) | 一种治疗坐骨神经痛的中药 | |
| CN102988858A (zh) | 治疗腰腿酸痛、坐骨神经痛的中药组合物 | |
| CN102935205A (zh) | 一种治疗乳腺增生的中药组合物 | |
| CN104383464A (zh) | 一种治疗卵巢癌的中药组合物 | |
| CN104056224A (zh) | 一种治疗习惯性流产的药物及其制备方法 | |
| CN106214831A (zh) | 一种治疗白癜风的内服中药丸及其制备方法 | |
| CN106389991A (zh) | 男科病的脐疗药物组合物、及其制作方法和用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140423 |